Mayewell Capital
Overview
Mayewell Capital is a venture capital firm based in Bryn Mawr, Pennsylvania. The firm prefers to invest in the healthcare, life science, and biotechnology sectors. Mayewell Capital focuses on acquiring regional rights of drugs for commercialization in the Asia-Pacific region, engaging in equity investments in biotechs at the Pre-IPO stage, and facilitating the setup of biotechs in the APAC region.
Portfolio Companies
2
Website
mayewellcapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| ONL Therapeutics | Aug 2023 | Series C | Co-investor |
| ThirtyFiveBio | Apr 2025 | VC Round | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Mayewell Capital based?
Mayewell Capital is headquartered in Bryn Mawr, Pennsylvania, United States.
When was Mayewell Capital founded?
Founding year information for Mayewell Capital is not publicly available.
How many portfolio companies does Mayewell Capital have?
Mayewell Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in Mayewell Capital's portfolio?
Portfolio companies visible on Caplight include ONL Therapeutics, ThirtyFiveBio.
What was Mayewell Capital's most recent investment shown here?
Mayewell Capital's most recent investment in this portfolio sample was in ThirtyFiveBio in 2025.
What sectors does Mayewell Capital focus on?
Mayewell Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Mayewell Capital focus on?
Mayewell Capital typically invests at the Mid stage.
What is Mayewell Capital's AUM?
Mayewell Capital's assets under management are estimated between $0.0 and $50.0M.